A medicinal composition for treating or preventing thrombosis, embolism and aftereffects thereof, characterized by comprising a specific TAFIa inhibitor and a plasminogen activator that are to be administered in combination. A method for treating or preventing thrombosis, embolism and aftereffects thereof, characterized by comprising administering a specific TAFIa inhibitor and a plasminogen activator in combination to a warm-blooded animal.